Security Snapshot

PureTech Health plc - ADS (PRTC) Institutional Ownership

CUSIP: 746237106

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

5

Shares (Excl. Options)

94,656

Price

$16.70

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / ADS
Symbol
PRTC on Nasdaq
Price per share
$15.41
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
94,656
Total reported value
$1,584,443
% of total 13F portfolios
0%
Share change
-7,216
Value change
-$121,516
Number of holders
5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • PRTC - PureTech Health plc - ADS is tracked under CUSIP 746237106.
  • 5 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 6 to 5 between Q3 2025 and Q4 2025.
  • Reported value moved from $1,883,027 to $1,584,443.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 5 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 746237106?
CUSIP 746237106 identifies PRTC - PureTech Health plc - ADS in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 5 institutional investors reported holding 94,656 shares of PureTech Health plc - ADS (PRTC).

Institutional Holders of PureTech Health plc - ADS (PRTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 94,656 $1,584,443 -$121,516 $16.70 5
2025 Q3 101,872 $1,883,027 -$545,008 $18.50 6
2025 Q2 353,472 $2,333,850 +$242,312 $17.25 8
2025 Q1 392,476 $2,321,446 +$377,945 $19.78 6
2024 Q4 373,378 $1,872,691 +$1,335,557 $18.46 5
2024 Q3 28,747 $592,620 -$524,801 $20.62 4
2024 Q2 322,144 $1,205,418 +$580,064 $25.00 6
2024 Q1 24,057 $685,647 +$391,890 $28.50 4
2023 Q4 10,307 $290,420 -$1,567,422 $28.18 3
2023 Q3 80,769 $1,857,687 +$14,214 $23.00 4
2023 Q2 80,151 $2,397,803 +$13,749 $28.50 3
2023 Q1 79,653 $2,292,989 -$37,858,571 $28.99 3
2022 Q4 1,384,846 $6,896,192 +$6,567,533 $31.90 4
2022 Q3 70,020 $1,891,000 -$15,946,450 $38.50 2
2022 Q2 660,349 $2,520,000 +$2,405,372 $11.93 2
2022 Q1 30,020 $759,000 -$222,000 $37.63 2
2021 Q4 36,002 $1,333,000 -$1,734,602 $37.84 4
2021 Q3 82,814 $3,975,000 +$2,531,850 $48.13 4
2021 Q2 30,063 $1,473,000 -$3,119,143 $48.31 2
2021 Q1 594,729 $4,897,000 -$5,209 $29.90 4
2020 Q4 594,825 $4,776,000 +$4,776,000 $29.41 4
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .